Back

Molnupiravir or nirmatrelvir-ritonavir versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2024-05-24 infectious diseases Title + abstract only
View on medRxiv
Show abstract

BackgroundMolnupiravir and nirmatrelvir-ritonavir (Paxlovid) are oral antivirals that have been proposed as treatments for patients admitted to hospital with COVID-19. MethodsIn this randomised, controlled, open-label, adaptive platform trial, several potential treatments for patients hospitalised with COVID-19 pneumonia were evaluated. Molnupiravir and nirmatrelvir-ritonavir were assessed in separate comparisons in RECOVERY, both of which are reported here. Eligible and consenting adults could...

Predicted journal destinations

1
Clinical Infectious Diseases
219 training papers
Top 0.5% 16.8%
2
BMJ Open
553 training papers
Top 14% 10.4%
3
PLOS ONE
1737 training papers
Top 58% 10.4%
4
Open Forum Infectious Diseases
124 training papers
Top 0.6% 6.1%
5
Clinical Microbiology and Infection
54 training papers
Top 0.3% 3.9%
6
BMJ
49 training papers
Top 0.3% 3.9%
7
JAMA Network Open
125 training papers
Top 5% 3.7%
8
Nature Communications
483 training papers
Top 29% 3.7%
9
The Journal of Infectious Diseases
137 training papers
Top 5% 2.9%
10
New England Journal of Medicine
49 training papers
Top 0.9% 2.6%
11
Vaccine
140 training papers
Top 4% 1.8%
12
BMC Medicine
155 training papers
Top 14% 1.8%
13
International Journal of Infectious Diseases
115 training papers
Top 9% 1.8%
14
Journal of Infection
64 training papers
Top 2% 1.8%
15
PLOS Medicine
95 training papers
Top 6% 1.8%
16
The Lancet
16 training papers
#1 1.8%
17
BMC Infectious Diseases
110 training papers
Top 8% 1.8%
18
The Lancet Infectious Diseases
57 training papers
Top 3% 1.5%
19
Scientific Reports
701 training papers
Top 87% 1.5%
20
The Lancet Respiratory Medicine
16 training papers
Top 0.2% 1.1%
21
Journal of Medical Virology
95 training papers
Top 10% 1.1%
22
eClinicalMedicine
55 training papers
Top 4% 0.9%
23
PLOS Global Public Health
287 training papers
Top 31% 0.9%
24
Nature Medicine
88 training papers
Top 14% 0.9%
25
Frontiers in Medicine
99 training papers
Top 26% 0.7%
26
Trials
24 training papers
Top 4% 0.7%
27
Eurosurveillance
77 training papers
Top 16% 0.7%